Trials / Sponsors / Newave Pharmaceutical Inc
Newave Pharmaceutical Inc
Industry · 4 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL CLL / SLL, CLL (Chronic Lymphocytic Leukemia), CLL, Refractory | Phase 3 | 2026-01-30 |
| Recruiting | Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CM Non Hodgkin Lymphoma, Richter Transformation, Multiple Myeloma | Phase 1 | 2021-08-23 |
| Recruiting | Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies. CLL/SLL, Waldenstrom Macroglobulinemia, Follicular Lymphoma | Phase 1 | 2021-07-19 |
| Completed | Dose-Escalation Study of Oral Administration of LP-108 as Monotherapy and in Combination With Azacitidine in P AML/MDS, CMML, Relapse | Phase 1 | 2020-07-06 |